Article: Nicotinamide Riboside Boosts NAD+ to Improve Telomere Stability: Preclinical Findings

PrevNext
Healthy Aging & Longevity Orphan Disease Preclinical

Nicotinamide Riboside Boosts NAD+ to Improve Telomere Stability: Preclinical Findings

Synopsis

Telomere biology disorders (TBDs), such as dyskeratosis congenita (DC), are characterized by critically short telomeres and often lead to bone marrow failure. A key metabolic molecule, NAD+, is known to be reduced in DC models. This study used mice lacking telomerase (Tert−/−), which develop severely short telomeres, to examine whether boosting NAD+ levels with nicotinamide riboside (NR), a NAD+ precursor, could improve health outcomes affected by telomere dysfunction. The results showed that NR treatment reduced weight loss and improved telomere stability, lowering the systemic inflammation caused by telomere problems. Additionally, NR helped correct imbalances in blood cell production and reduced damage and inflammation in the small intestine after transplantation. These findings suggest that NAD+ supplementation through NR may be a promising approach to support health in conditions involving telomere shortening.

Journal

GeroScience

Share

Read more

Neurological Health

Nicotinamide Riboside Boosts NAD+, to Reduce Sleep Need and Support Brain Energy: Preclinical Findings

SynopsisNon-rapid eye movement sleep (NREMS) is linked to lower brain glucose use, which slows metabolic reactions involving NAD+. This study tested whether boosting NAD+ with nicotinamide riboside...

Read more
Diabetes

Nicotinamide Riboside and Nicotinamide Mononucleotide Restore Nerve Function in Diabetic Neuropathy: Preclinical Findings

SynopsisReduced NAD+ signaling contributes to nerve degeneration in diabetic peripheral neuropathy. Researchers tested NAD+ precursors, nicotinamide riboside and nicotinamide mononucleotide, in cul...

Read more